Vafseo Outcomes In-Center Experience
Public ClinicalTrials.gov record NCT06520826. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety of Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Hemodialysis Subjects: Vafseo Outcomes In-Center Experience
Study identification
- NCT ID
- NCT06520826
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- USRC Kidney Research
- Network
- Enrollment
- 2,200 participants
Conditions and interventions
Conditions
Interventions
- Erythropoiesis Stimulating Agent Drug
- Vadadustat Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 19, 2024
- Primary completion
- Jun 29, 2026
- Completion
- Jun 29, 2026
- Last update posted
- Mar 9, 2026
2024 – 2026
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USRC Kidney Research | Lone Tree | Colorado | 80124 | — |
| Nephrology and Hypertension Specialists, PC | Dalton | Georgia | 30720 | — |
| US Renal Care - Gallup | Gallup | New Mexico | 87301 | — |
| Dallas Renal Group | Dallas | Texas | 75230 | — |
| US Renal Care - Live Oak | Live Oak | Texas | 78233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06520826, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06520826 live on ClinicalTrials.gov.